Actividades preventivas cardiovasculares en atención primaria

Villar Álvarez, F; Maiques Galán, A; Brotons Cuixart, C; Torcal Laguna, J; Ortega Sánchez-Pinilla, R; Vilaseca Canals, J; Forés García, D; Banegas Banegas, J. R; Lobos Bejarano, J. M; Orozco Beltrán, D; Gil Guillén, V. F; Llor Vila, C; Lorenzo Piqueres, A.
Aten. prim. (Barc., Ed. impr.) ; 32(supl.2): 15-29, dic. 2003.
Artículo en Es | IBECS (España) | ID: ibc-30215

Documentos relacionados

  1. Formation of Antihyperlipidemic Nano-Ezetimibe from Volatile Microemulsion Template for Enhanced Dissolution Profile.
  2. Step-wise Lipid-Lowering Therapy: Thinking Beyond the Guidelines.
  3. [The general trend of combined use of lipid-lowering drugs].
  4. Fibrates Affect Levels of Phosphorylated p38 in Intestinal Cells in a Differentiation-Dependent Manner.
  5. A case of liver injury during lipid-lowering therapy.
  6. An Insight into Antihyperlipidemic Effects of Polysaccharides from Natural Resources.
  7. Aromatic Acids and Leucine Derivatives Produced from the Deep-Sea Actinomycetes <i>Streptomyces</i><i>chumphonensis</i> SCSIO15079 with Antihyperlipidemic Activities.
  8. Benefits of Bempedoic Acid - Clearer Now.
  9. Trends in PCSK9 inhibitor utilization in the United States, Europe, and other countries: An analysis of international sales data.
  10. Hederagenin Exerts Potential Antilipemic Effect via p38MAPK Pathway in Oleic Acid-induced HepG2 cells and in Hyperlipidemic Rats.